APAnastasia Sergeevna Panova

Anastasia Sergeevna Panova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Anastasia Sergeevna Panova has a total of 41 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Contact transmission of fur seal-derived genotype A3 influenza A(H5N1) virus in ferrets

    by Andrey S. Gudymo, Natalia P. Kolosova, Anastasia S. Panova, Kiunnei N. Shadrinova, Natalia I. Goncharova, Olga N. Perfilieva, Natalia V. Danilchenko, Anastasia A. Moiseeva, Elena I. Danilenko, Natalia N. Vasiltsova, et al.

  • Review of the Epizootic and Epidemic Situation regarding Highly Pathogenic Avian Influenza in Russia and Globally in 2025

    by A. I. Enikeeva, A. S. Panova, N. N. Vasiltsova, A. V. Danilenko, K. N. Shadrinova, S. V. Svyatchenko, K. I. Ivanova, G. S. Onkhonova, N. I. Goncharova, T. V. Tregubchak, et al.

    In 2025, high epizootic activity of highly pathogenic avian influenza virus (HPAIV) persisted globally, as evidenced by more than 7,000 outbreaks reported in poultry and wild birds across 75 countries, resulting in mortality or culling of birds exceeding 98 million specimens. The majority of outbreaks worldwide were associated with HPAIV A(H5N1) clade 2.3.4.4b, which has remained the predominant lineage in global circulation since 2021. In addition to the dominant A(H5N1) clade 2.3.4.4b subtype, circulation of other highly pathogenic subtypes was observed, including A(H5N5), A(H5N2), A(H5N8), and A(H5N9), as well as A(H7), indicating ongoing evolution of avian influenza viruses in natural and anthropogenic ecosystems. In the United States and several other countries, HPAIV A(H5N1) caused numerous infections in wild and domestic mammals as well as in humans. In 2025, the world’s first human case of A(H5N5) influenza was documented in the United States. A total of 74 zoonotic HPAIV human infections were reported globally in 2025, including 32 cases caused by A(H5) viruses of various clades (2.3.4.4b, 2.3.2.1e, 2.3.2.1a), reflecting a continuing increase in interspecies transmission that poses a potential public health threat. In the Russian Federation, high epizootic activity of HPAIV persisted throughout 2025, with outbreaks caused by A(H5N1) clade 2.3.4.4b viruses reported in both wild and domestic birds. Notably, in the Russian Far East, circulation of an A(H5N1) virus carrying mammalian-adaptive mutations associated with increased virulence in mammals was detected. Additionally, amino acid substitutions in antigenic sites were identified in several A(H5N1) isolates. Despite ongoing virus evolution, no substantial alterations in the antigenic properties of HPAIV A(H5N1) strains circulating in the Russian Federation have been observed to date.


  • Detection of D222G/N Mutations in Fatal Cases in A(H1N1)pdm09 Influenza Viruses Dominant in the 2024–2025 Season in the Russian Federation

    by Anastasia S. Panova, Natalia P. Kolosova, Alexey V. Danilenko, Nikita D. Boldyrev, Kiunnei N. Shadrinova, Svetlana V. Svyatchenko, Anastasiya A. Moiseeva, Elena I. Danilenko, Galina S. Onkhonova, Natalia N. Goncharova, et al.

    Introduction: Seasonal influenza circulates in an epidemic pattern, with periodic shifts in the dominant subtype driven by antigenic drift and population immunity. Mutations in surface proteins – particularly within the hemagglutinin receptor-binding site (RBS) – enable the virus to evade host immune responses. Among these, the D222G/N substitution has been associated with increased virulence of A(H1N1)pdm09 viruses. Objective: Genetic characterization of viruses detected in influenza cases in the Russian Federation in the 2024–2025 epidemic season. Materials and methods: From September 10, 2024, to June 19, 2025, 1,931 specimens from patients with influenza, including 240 autopsy samples, were tested by RT-PCR. For 420 samples with sufficient genetic material, influenza virus genome sequences were obtained using NGS. Results: During the 2024–2025 flu season, A(H1N1)pdm09 viruses predominated in the Russian Federation. Influenza B/Victoria lineage viruses were less frequent while influenza A (H3N2) cases were sporadic. Most fatal cases occurred in individuals belonging to risk groups, with a notably low vaccination coverage among them. Among fatal A(H1N1)pdm09 cases, the HA-D222N mutation – a marker of enhanced virulence – was detected in the major viral variant in 19.0 % of sequenced samples. Additionally, D222G/N mutations were identified in minor variants in 10.1 % of fatal cases. Notably, the D222N mutation in the major variant was also found in one recovered A(H1N1)pdm09 case (0.5 %). Resistance markers to antiviral drugs – oseltamivir (1.9 %) and baloxavir marboxil (0.4 %) were detected in 6 of all sequenced A(H1N1)pdm09 viruses (2.3 %). Conclusion: The detection of HA-D222G/N mutations associated with increased virulence and fatality from A(H1N1)pdm09 viruses underscores the importance of vaccination as a key preventive measure, particularly for population groups at risk, and timely treatment for influenza.

  • Seroprevalence of anti-influenza antibodies in humans and characterization of seasonal influenza viruses isolated in Russia during the 2023–2024 flu season

    by Svetlana V. Svyatchenko, Nikita D. Boldyrev, Anastasia S. Panova, Natalia P. Kolosova, Kiunnei N. Shadrinova, Natalia I. Goncharova, Galina S. Onkhonova, Alina R. Muratova, Alexey V. Danilenko, Elena I. Danilenko, et al.

    The 2023–2024 flu season in Russia was dominated by influenza A(H3N2) viruses. In this study, we isolated seasonal influenza viruses from human respiratory specimens, analyzed their genetic and antigenic properties, and assessed their susceptibility to neuraminidase inhibitors. In total, we isolated 207 influenza virus isolates. Of them, 95.2% were subtyped as A(H3N2), 1.9% as A(H1N1)pdm09, and 2.9% as B/Victoria influenza viruses. The hemagglutinin sequences of the A(H3N2) isolates showed that they belonged to several subclades within the 2a.3a.1 genetic group, with the J2 subclade being predominant. Despite their genetic diversity, all A(H3N2) strains tested using a hemagglutination inhibition assay were antigenically similar to the egg-propagated vaccine strain A/Darwin/09/2021(H3N2). The B/Victoria virus isolates belonged to the C.5 and C.5.7 subclades of the genetic group V1A.3a.2 and were antigenically similar to cell- and egg-propagated variants of the vaccine strain B/Austria/1359417/2021. All of the A(H1N1)pdm09 isolates belonged to the 6B.1A.5a.2a genetic clade and were well-recognized by a ferret antiserum raised against a cell-propagated A/Wisconsin/67/2022(H1N1pdm09)-like reference strain. All of the tested isolates were susceptible to oseltamivir and zanamivir, including two A(H1N1)pdm09 strains with an NA-S247N substitution. Seroprevalence analysis showed that 60%, 54%, and 46% of the human blood samples tested were seropositive for the A(H3N2), A(H1N1)pdm09 and B/Victoria antigens from the 2022–2023 vaccine.


  • Open Access

    Epizootiological and Epidemiological Situation on Highly Pathogenic Avian Influenza Globally and in the Russian Federation in 2024

    by N. N. Vasiltsova, A. S. Panova, V. N. Petrov, A. V. Danilenko, K. N. Shadrinova, S. V. Svyatchenko, K. I. Ivanova, G. S. Onkhonova, N. I. Goncharova, V. Yu. Marchenko

    The aim of the work was to analyze the circulation of the most epidemiologically significant variants of the avian influenza virus in the world and across Russia in 2024. The global situation on highly pathogenic avian influenza remained tense in 2024. The disease affected 68 countries, resulting in the death or culling of about 19 million poultry. In addition, there was a large number of influenza A(H5N1) virus detections in wild and domestic mammals, predominantly in the United States. Those included outbreaks on dairy farms that affected herds throughout the year, encompassing more than 900 dairy farms in 16 states by the year’s end and causing infection of 40 farm workers in four states. The A(H5N1) viruses detected in farm workers contained mammalian adaptation mutations. In total, more than 100 human infections with zoonotic variants of influenza virus were reported in 2024, with influenza A(H5N1) virus detected in 81 cases. Apart from outbreaks of A(H5N1), other influenza virus variants, such as A(H5N6), A(H5N8), A(H5N5), A(H5N2), were circulating worldwide. Outbreaks among poultry caused by different subtypes of influenza A(H7) virus were also reported in a number of countries. In Russia, the situation on highly pathogenic influenza virus in 2024 was less tense. All detected influenza A(H5N1) viruses belonged to clade 2.3.4.4b and were genetically similar to the vaccine strains recommended by WHO. Isolated strains were antigenically similar to a reference strain A/goose/Tyumen/359- 13/2021(H5N1), which had HA1 sequence identical to the vaccine strain A/Astrakhan/3212/2020(H5N8). In addition, an influenza A(H9N2) virus was isolated in 2024. The study of this strain showed that it belongs to the clade Y439 and does not contain mutations associated with increased pathogenicity and drug resistance.


  • Open Access

    Influenza Viruses Detected in Lethal Cases in the Russian Federation in the 2023–2024 Respiratory Virus Season

    by Nikita D. Boldyrev, Anastasia S. Panova, Natalia P. Kolosova, Alexey V. Danilenko, Kiunnei N. Shadrinova, Svetlana V. Svyatchenko, Galina S. Onkhonova, Alina R. Muratova, Natalia N. Goncharova, Andrei S. Gudymo, et al.

    Introduction: Influenza is a highly contagious disease which can cause severe complications and even death, particularly in high-risk populations. Continuous monitoring and careful testing of seasonal influenza viruses, especially for severe cases, is necessary to develop and optimize prevention and treatment. Objective: To establish genetic and antigenic characteristics of influenza viruses detected in lethal cases in the Russian Federation in the 2023–2024 respiratory virus season. Materials and methods: From September 29, 2023 to June 1, 2024, 859 specimens from influenza cases (nasopharyngeal swabs) and 101 autopsy specimens of trachea, bronchi, and lungs from lethal cases of the disease from 57 regions of the Russian Federation were analyzed by PCR. For those with a sufficient amount of genetic material, whole-genome sequencing was performed using the Illumina MiSeq platform. Results: The 2023–2024 influenza season in the Russian Federation was characterized by the dominance of A/H3N2 viruses of subclade 2a.3a.1. Influenza A/H1N1pdm09 and influenza type B viruses were detected to a lesser extent in that period. Additional diversification of A/H3N2 viruses was observed during the season with accumulation of amino acid substitutions in the hemagglutinin antigenic sites. Most lethal cases were among those at high risk and unvaccinated. No mutations associated with increased pathogenicity and virulence were identified in A/H3N2 viruses from lethal cases. No molecular markers of drug resistance to neuraminidase inhibitors and baloxavir marboxil were identified in all viruses tested in the 2023–2024 season. Conclusion: Influenza A/H3N2 viruses from the lethal cases of the diseases tested at the State Research Center for Virology and Biotechnology “Vector” in the 2023–2024 respiratory virus season were similar to those detected in recovered patients. The isolated viruses were genetically and antigenically similar to the vaccine strain and had no markers of increased pathogenicity or drug resistance.


  • Open Access

    Review on the Epizootiological Situation on Highly Pathogenic Avian Influenza Globally and in Russia in 2023

    by N. N. Vasil’tSova, A. S. Panova, V. N. Petrov, A. V. Danilenko, S. V. Svyatchenko, K. I. Ivanova, G. S. Onkhonova, N. I. Goncharova, A. B. Ryzhikov, V. Yu. Marchenko

    The year 2023 saw a challenging epizootiological and epidemiological situation regarding highly pathogenic avian influenza. The virus affected 150 bird species and dozens of mammal species. More than 650 outbreaks were reported in poultry across 29 countries, resulting in the death or destruction of approximately 19 million specimens. There was a high incidence of the influenza among wild birds (approximately 3,000 outbreaks in 65 countries) and mammals (more than 16,000 cases). The majority of outbreaks in wild birds, poultry and mammals were caused by influenza A(H5N1) clade 2.3.4.4b viruses. Many countries in Europe, Asia, Africa, North and South America experienced the outbreaks throughout the year. For the first time, a polar bear death from A(H5N1) virus was documented. Moreover, molecular markers of virus adaptation to mammals were found in PB2 proteins of 50 % of influenza A(H5N1) viruses that caused the death of animals. During the year 2023, human infections with highly pathogenic avian influenza A(H5N1) viruses were reported in Cambodia, Chile, China, and the UK. In addition, human infections with A(H3N8), A(H5N6), A(H9N2) and A(H10N5) viruses were reported in China. In Russia in 2023, outbreaks among wild birds and poultry were registered in 25 regions, as well as an outbreak among fur seals in the Sakhalin Region. The stated outbreaks were caused by highly virulent influenza A(H5N1) clade 2.3.4.4b. Hemagglutinin sequences of all Russian viruses analyzed in this study in 2023 were genetically close to the WHO candidate vaccine strains A/Astrakhan/3212/2020 (H5N8), A/chicken/ Ghana/AVL-763_21VIR7050-39/2021 (H5N1) and A/American Wigeon/South Carolina/22-000345-001/2021 (H5N1). All studied A(H5N1) viruses were antigenically similar to the A/Astrakhan/3212/2020 vaccine strain.


  • Comparative analysis of influenza viruses isolated from first and severe cases in Russia in epidemiological seasons before and during COVID-19 pandemic (2019—2023)

    by N.D. Boldyrev, A.S. Panova, N.P. Kolosova, A.V. Danilenko, G.S. Onkhonova, S.V. Svyatchenko, V.YU. Marchenko, A.B. Ryzhikov

    Вирус гриппа является одним из наиболее опасных возбудителей респираторных заболеваний, и его изучение важно для эпидемиологического контроля, особенно в случае социркуляции с SARS-CoV-2. ЦЕЛЬ ИССЛЕДОВАНИЯ Сравнительный анализ вирусов гриппа, выделенных от первых и тяжелых случаев, в эпидемических сезонах до и во время пандемии COVID-19 в России. МАТЕРИАЛ И МЕТОДЫ В основе статьи лежат результаты мониторинга циркуляции вирусов сезонного гриппа, полученные в 2019—2023 гг. Пробы от первых и тяжелых случаев заболевания гриппом были изучены методами ПЦР в реальном времени и полногеномного секвенирования. Была проведена антигенная характеризация изолированных вирусов, исследована их чувствительность к противовирусным препаратам. РЕЗУЛЬТАТЫ Сезон гриппа в 2019—2020 гг. в России стал последним эпидемическим сезоном перед пандемией COVID-19 с преимущественной социркуляцией вирусов гриппа B и гриппа A/H1N1pdm09. После начала пандемии в сезоне 2020—2021 гг. вирус гриппа в России практически отсутствовал и выявлялся спорадически. Циркуляция вируса возобновилась в сезоне 2021—2022 гг. с доминированием A/H3N2 (клада 3C.2a1b.2a2) и продолжилась в сезоне 2022—2023 гг. с доминированием А/H1N1pdm09 (клада 6B.1A.5a.2a) и распространением вирусов гриппа B/Victoria (клада V1A.3a.2), антигенно отличавшихся от вирусов, циркулировавших до пандемии COVID-19. Генетический анализ мутаций D222G/N в гемагглютинине вирусов A/H1N1pdm09, ассоциированных с повышенной тяжестью заболевания, выявил примерно эквивалентный отбор мутаций D222G и D222N в сезоне 2019—2020 гг. и повышенную встречаемость варианта D222N в сезоне 2022—2023 гг. ЗАКЛЮЧЕНИЕ Социркуляция с SARS-CoV-2, возвращение циркуляции гриппа к эпидемическому уровню, возникновение новых антигенных вариантов и факторов патогенности подчеркивают необходимость мониторинга и изучения вирусов гриппа для эпидемиологического анализа и прогноза, а также для разработки и применения эффективных мер по защите населения.


  • Comparative Analysis of Influenza Viruses Isolated from Early and Severe Cases in Epidemic Seasons before and during the COVID-19 Pandemic in Russia (2019–2023)

    by N. D. Boldyrev, A. S. Panova, N. P. Kolosova, A. V. Danilenko, S. V. Svyatchenko, G. S. Onkhonova, V. Yu. Marchenko, A. B. Ryzhikov

    The influenza virus is one of the most dangerous causative agents of respiratory diseases, and its study is important for epidemiological control, especial